Market Access and Patient Activation
Delivering end-to-end services to ensure patients in the UK get efficient access to pharmaceutical therapeutics and diagnostics.


This session focuses on how pharmaceutical companies can better align with the NHS to ensure successful product launches. It introduces the three core pillars of Launch Excellence:
Delivering end-to-end services to ensure patients in the UK get efficient access to pharmaceutical therapeutics and diagnostics.